Some peptides are used as FDA-approved medications
A meta-analysis of large randomized controlled trials examining the association between incretin-based therapies and AP revealed an 82% (95% CI, 1.172.82) higher likelihood of developing AP when using these drugs compared to conventional therapy (Roshanov and Dennis, 2015)
Lencer (Boston Childrens Hospital, Harvard Medical School and Harvard Digestive Diseases center, United States) were cultured in MCDB 131 medium (Gibco) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Gibco), 2 mM l-glutamine (Gibco), 25 g/mL streptomycin (Gibco), 25 U/mL penicillin (Gibco), 10 ng/mL recombinant mouse epidermal growth factor (Gibco), and 1 g/mL hydrocortisone (Sigma-Aldrich), at 37 C in a humidified atmosphere of 5% CO 2
The short answer is a clear yes
Each bottle is intended exclusively for research use and supplied to strict quality standards